About: Osteopenia is a research topic. Over the lifetime, 8917 publications have been published within this topic receiving 306822 citations. The topic is also known as: decreased bone density.
TL;DR: Osteoporosis is widely viewed as a major public health concern, but the exact magnitude of the problem is uncertain and likely to depend on how the condition is defined, and the design and implementation of control programs directed at this major health problem must be given.
Abstract: Osteoporosis is widely viewed as a major public health concern, but the exact magnitude of the problem is uncertain and likely to depend on how the condition is defined. Noninvasive bone mineral measurements can be used to define a state of heightened fracture risk (osteopenia), or the ultimate clinical manifestation of fracture can be assessed (established osteoporosis). If bone mineral measurements more than 2 standard deviations below the mean of young normal women represent osteopenia, then 45% of white women aged 50 years and over have the condition at one or more sites in the hip, spine, or forearm on the basis of population-based data from Rochester, Minnesota. A smaller proportion is affected at each specific skeletal site: 32% have bone mineral values this low in the lumbar spine, 29% in either of two regions in the proximal femur, and 26% in the midradius. Although this overall estimate is substantial, some other serious chronic diseases are almost as common. More importantly, low bone mass is associated with adverse health outcomes, especially fractures. The lifetime risk of any fracture of the hip, spine, or distal forearm is almost 40% in white women and 13% in white men from age 50 years onward. If the enormous costs associated with these fractures are to be reduced, increased attention must be given to the design and implementation of control programs directed at this major health problem.
TL;DR: Ovariectomy induced bone loss in the rat and postmenopausal bone loss share many similar characteristics, including: increased rate of bone turnover with resorption exceeding formation; and initial rapid phase of bone loss followed by a much slower phase.
TL;DR: It is suggested that the HBM mutation confers a unique osteogenic activity in bone remodeling, and this understanding may facilitate the development of novel therapies for the treatment of osteoporosis.
Abstract: Osteoporosis is a complex disease that affects >10 million people in the United States and results in 1.5 million fractures annually. In addition, the high prevalence of osteopenia (low bone mass) in the general population places a large number of people at risk for developing the disease. In an effort to identify genetic factors influencing bone density, we characterized a family that includes individuals who possess exceptionally dense bones but are otherwise phenotypically normal. This high–bone-mass trait (HBM) was originally localized by linkage analysis to chromosome 11q12-13. We refined the interval by extending the pedigree and genotyping additional markers. A systematic search for mutations that segregated with the HBM phenotype uncovered an amino acid change, in a predicted β-propeller module of the low-density lipoprotein receptor–related protein 5 (LRP5), that results in the HBM phenotype. During analysis of >1,000 individuals, this mutation was observed only in affected individuals from the HBM kindred. By use of in situ hybridization to rat tibia, expression of LRP5 was detected in areas of bone involved in remodeling. Our findings suggest that the HBM mutation confers a unique osteogenic activity in bone remodeling, and this understanding may facilitate the development of novel therapies for the treatment of osteoporosis.
TL;DR: The lesser genetic contribution to proximal femur and distal forearm bone mass compared with the spine suggests that environmental factors are of greater importance in the aetiology of osteopenia of the hip and wrist.
Abstract: The relative importance of genetic factors in determining bone mass in different parts of the skeleton is poorly understood. Lumbar spine and proximal femur bone mineral density and forearm bone mineral content were measured by photon absorptiometry in 38 monozygotic and 27 dizygotic twin pairs. Bone mineral density was significantly more highly correlated in monozygotic than in dizygotic twins for the spine and proximal femur and in the forearm of premenopausal twin pairs, which is consistent with significant genetic contributions to bone mass at all these sites. The lesser genetic contribution to proximal femur and distal forearm bone mass compared with the spine suggests that environmental factors are of greater importance in the aetiology of osteopenia of the hip and wrist. This is the first demonstration of a genetic contribution to bone mass of the spine and proximal femur in adults and confirms similar findings of the forearm. Furthermore, bivariate analysis suggested that a single gene or set of genes determines bone mass at all sites.
TL;DR: Age, personal or family history of fracture, Asian or Hispanic heritage, smoking, and cortisone use were associated with significantly increased likelihood of osteoporosis; higher body mass index, African American heritage, estrogen or diuretic use, exercise, and alcohol consumption significantly decreased the likelihood.
Abstract: ContextLarge segments of the population at risk for osteoporosis and fracture
have not been evaluated, and the usefulness of peripheral measurements for
short-term prediction of fracture risk is uncertain.ObjectivesTo describe the occurrence of low bone mineral density (BMD) in postmenopausal
women, its risk factors, and fracture incidence during short-term follow-up.DesignThe National Osteoporosis Risk Assessment, a longitudinal observational
study initiated September 1997 to March 1999, with approximately 12 months
of subsequent follow-up.Setting and ParticipantsA total of 200 160 ambulatory postmenopausal women aged 50 years
or older with no previous osteoporosis diagnosis, derived from 4236 primary
care practices in 34 states.Main Outcome MeasuresBaseline BMD T scores, obtained from peripheral bone densitometry performed
at the heel, finger, or forearm; risk factors for low BMD, derived from questionnaire
responses; and clinical fracture rates at 12-month follow-up.ResultsUsing World Health Organization criteria, 39.6% had osteopenia (T score
of –1 to –2.49) and 7.2% had osteoporosis (T score ≤−2.5).
Age, personal or family history of fracture, Asian or Hispanic heritage, smoking,
and cortisone use were associated with significantly increased likelihood
of osteoporosis; higher body mass index, African American heritage, estrogen
or diuretic use, exercise, and alcohol consumption significantly decreased
the likelihood. Among the 163 979 participants with follow-up information,
osteoporosis was associated with a fracture rate approximately 4 times that
of normal BMD (rate ratio, 4.03; 95% confidence interval [CI], 3.59-4.53)
and osteopenia was associated with a 1.8-fold higher rate (95% CI, 1.49-2.18).ConclusionsAlmost half of this population had previously undetected low BMD, including
7% with osteoporosis. Peripheral BMD results were highly predictive of fracture
risk. Given the economic and social costs of osteoporotic fractures, strategies
to identify and manage osteoporosis in the primary care setting need to be
established and implemented.